Evidence map›Paper›PMID 37620305›Full record

ArticleNature communications2023

Structural basis of lipid-droplet localization of 17-beta-hydroxysteroid dehydrogenase 13.

Shenping Liu, Ruth F Sommese, Nicole L Nedoma, Lucy Mae Stevens, Jason K Dutra, Liying Zhang, David J Edmonds, Yang Wang, Michelle Garnsey, Michelle F Clasquin

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Essential Biology of Lipid Droplets.Annual review of biochemistry · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Shenping LiuMedicine Design, Pfizer Inc, Groton, CT, 06340, USA. Shenping.Liu@pfizer.com.ORCID http://orcid.org/0000-0001-9400-3007
Ruth F SommeseMedicine Design, Pfizer Inc, Groton, CT, 06340, USA. Ruth.Sommese@pfizer.com.
Nicole L NedomaMedicine Design, Pfizer Inc, Groton, CT, 06340, USA.ORCID http://orcid.org/0009-0000-3809-9120
Lucy Mae StevensMedicine Design, Pfizer Inc, Groton, CT, 06340, USA.
Jason K DutraMedicine Design, Pfizer Inc, Cambridge, MA, 02139, USA.
Liying ZhangMedicine Design, Pfizer Inc, Cambridge, MA, 02139, USA.
David J EdmondsMedicine Design, Pfizer Inc, Cambridge, MA, 02139, USA.ORCID http://orcid.org/0000-0001-9234-8618
Yang WangMedicine Design, Pfizer Inc, Cambridge, MA, 02139, USA.
Michelle GarnseyMedicine Design, Pfizer Inc, Cambridge, MA, 02139, USA.ORCID http://orcid.org/0000-0003-1226-1868
Michelle F ClasquinInternal Medicine Research Unit, Pfizer Inc, Cambridge, MA, 02139, USA.ORCID http://orcid.org/0000-0002-5361-6859
Pfizer (United States) · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USRoche (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydroxysteroid 17-beta-dehydrogenase 13 (HSD17B13) is a hepatic lipid droplet-associated enzyme that is upregulated in patients with non-alcoholic fatty liver disease. Recently, there have been several reports that predicted loss of function variants in HSD17B13 protect against the progression of steatosis to non-alcoholic steatohepatitis with fibrosis and hepatocellular carcinoma. Here we report crystal structures of full length HSD17B13 in complex with its NAD

Indexed as

17-Hydroxysteroid DehydrogenasesCarcinoma, HepatocellularLiver NeoplasmsNon-alcoholic Fatty Liver DiseaseHumansLipid Droplet Associated ProteinsLipids17-Hydroxysteroid DehydrogenasesHSD17B13 protein, humanLipid Droplet Associated ProteinsLipids

Identifiers

PMID37620305
PMCPMC10449848
OpenAlexW4386136752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.